Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|April 15, 2019
CPhI North America Partners with iBIO to Foster Female Leadership in Biopharma
Author(s)Pharmaceutical Technology Editors
The partnership includes a $10,000 donation to fund Illinois Biotechnology Innovation Organization (iBIO) STEM programming for girls in grades three through eight.
Advertisement
On April 12, 2019, CPhI North America, a major North American pharma supply chain event, announced a partnership with Illinois Biotechnology Innovation Organization (iBIO) under which CPhI North America will donate $10,000 to the iBIO EDUCATE Center, whichdelivers industry-led STEM programs to teachers and students. The partnership aims to support STEM programming for girls and foster female leadership in the biopharma industry. In addition to this donation, iBIO members will receive 30% off the event attendee rate for the upcoming CPhI North America 2019 event, being held from April 30–May 2 in Chicago, IL.
iBIO is an association that comprises more than 85,000 life-science employees at member companies, universities, service providers, and venture firms throughout Illinois.
CPhI North America’s donation will be used to fund iBIO’s Stellar Girls and STEM Girls Camp. Both programs work to introduce girls in grades three through eight to careers in STEM. Stellar Girls conducts after-school programming and the STEM Girls Camp holds a five-day summer camp.
“We’re delighted to support iBIO in its Stellar Girls and STEM Girls Camp initiatives as part of CPhI North America’s dedication to the promotion and growth of female interest and success in the biopharma field,” said Joseph Marks, brand director, CPhI North America, in a company press release. “As an industry-leading event committed to inclusivity and equality, we’re also proud to present the third annual Women in Leadership Forum, which this year focuses on the theme ‘From Manager to Leader,’ and will see senior leaders from the pharmaceutical industry sharing inspirations and defining moments in their leadership journeys to date.”
CPhI North America’s Women in Leadership Forum takes place Thursday, May 2, 8:00am–11:00am. iBIO will be presented with the $10,000 donation check at the forum.
IBIO members can register for CPhI North America 2019
Source:
Advertisement
Related to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement